Ligand validation:3T2Q

149: D-galactonolactone

149 is a Ligand Of Interest in 3T2Q designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3T2Q_149_C_2001	34%	23%	0.239	0.926	2.41	0.83	2	1	3	0	100%	1
3T2Q_149_B_2001	26%	18%	0.231	0.875	2.57	1.03	1	2	0	0	100%	1
3T2Q_149_A_2001	24%	24%	0.259	0.89	2.38	0.8	2	-	0	0	100%	1
3T2Q_149_D_2001	16%	26%	0.262	0.832	2.33	0.71	2	-	3	0	100%	1
1JZ5_149_D_2001	98%	15%	0.063	0.984	1.94	1.8	3	4	0	0	100%	1
3T0D_149_B_2001	94%	21%	0.081	0.98	2.46	0.92	2	1	0	0	100%	1
3T09_149_D_2001	92%	20%	0.075	0.964	2.36	1.06	2	1	0	0	100%	1
3I3B_149_C_2001	88%	50%	0.092	0.968	1.16	0.78	2	-	0	0	100%	1
3MV0_149_4_2001	88%	56%	0.093	0.969	0.91	0.77	1	-	0	0	100%	1
3VDB_149_C_2001	84%	20%	0.108	0.969	2.37	1.06	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.